EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Neuropathic pain: Evidence based recommendations

Xavier Moisset

La Presse Médicale · 2024-06 · 53 (2) · 104232

DOI: 10.1016/j.lpm.2024.104232 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift La Presse Médicale, 2024-06. Verfasst von Xavier Moisset. Beteiligte Einrichtung: Clermont Auvergne University, University Hospital Center of Clermont-Ferrand, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France. Electronic address…. Hauptthemen laut MEDLINE: Neuralgia, Practice Guidelines as Topic, Evidence-Based Medicine. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain continues to be a significant problem that lacks effective solutions for every single patient. In 2015, international guidelines (NeuPSIG) were published, while the French recommendations were updated in 2020. The purpose of this minireview is to provide an update on the process of developing evidence-based recommendations and explore potential changes to the current recommendations. Primary treatments for neuropathic pain include selective serotonin-norepinephrine reuptake inhibitors (SNRIs) such as duloxetine and venlafaxine, gabapentin, tricyclic antidepressants, as well as topical lidocaine and transcutaneous electrical nerve stimulation, which are specifically suggested for focal peripheral neuropathic pain. Pregabalin is a first line treatment according to international guidelines but second-line in the more recent French guidelines, due to lower efficacy seen in more recent studies and misuse risk. Additionally, tramadol, combination therapies, and psychotherapy as adjuncts are proposed second line; high-concentration capsaicin patches, and botulinum toxin A are proposed specifically for focal peripheral neuropathic pain. In cases where primary and secondary treatments prove insufficient, third-line options come into play. These include high-frequency repetitive transcranial magnetic stimulation (rTMS) targeting the motor cortex, spinal cord stimulation, and the use of strong opioids when no alternative is available. To ensure optimal management of neuropathic pain in real-life situations, it is imperative to disseminate these recommendations widely and secure the acceptance of practitioners. By doing so, we can bridge the gap between theory and practice, and enhance the overall care and treatment of individuals suffering from neuropathic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaPractice Guidelines as TopicEvidence-Based MedicineHumansAnalgesics

Stichwörter der Autor:innen

Neuropathic painNeurostimulationPharmacotherapyPsychotherapyRecommendations

Substanzen

Analgesics

Autor:innen und Institutionen

  • Clermont Auvergne University, University Hospital Center of Clermont-Ferrand, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France. Electronic address: xavier.moisset@gmail.com.

Zitieren

APA

Moisset, X. (2024). Neuropathic pain: Evidence based recommendations. La Presse Médicale, 53(2), 104232. https://doi.org/10.1016/j.lpm.2024.104232

Vancouver

Moisset X. Neuropathic pain: Evidence based recommendations. La Presse Médicale. 2024;53(2):104232. doi:10.1016/j.lpm.2024.104232

BibTeX
@article{Moisset2024,
  author = {Moisset, Xavier},
  title = {Neuropathic pain: Evidence based recommendations},
  journal = {La Presse Médicale},
  year = {2024},
  volume = {53},
  number = {2},
  pages = {104232},
  doi = {10.1016/j.lpm.2024.104232}
}
Kostenlos starten →